cancer trials australia
ABT-199 BH-3 Mimetic Enters Phase Ia Trial For Chronic Lymphocytic Leukemia
A molecule discovered 20 years ago at the Walter and Eliza Hall Institute in Australia is now entering clinical trials to treat chronic lymphocytic leukemia.